A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma
Clinical trial NCT01377025 · UNKNOWN
Trial details
- NCT number
- NCT01377025
- Sponsor
- Prof. Dr. med. Max. E. Scheulen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2016-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.